NCT00003816 arm group f49759ffe38c130161a2697b55a1b779 [clinicaltrials_resource:NCT00003816/arm-group/f49759ffe38c130161a2697b55a1b779]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003816 arm group f49759ffe38c130161a2697b55a1b779 [clinicaltrials_resource:NCT00003816/arm-group/f49759ffe38c130161a2697b55a1b779]
Bio2RDF identifier
NCT00003816/arm-group/f49759ffe38c130161a2697b55a1b779
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 9759ffe38c130161a2697b55a1b779
description [clinicaltrials_vocabulary:description]
Patients receive cyclophospham ...... er 4-8 hours on days -5 to -3.
identifier
clinicaltrials_resource:NCT00003816/arm-group/f49759ffe38c130161a2697b55a1b779
title
NCT00003816 arm group f49759ffe38c130161a2697b55a1b779
@en
type
label
NCT00003816 arm group f49759ff ...... 759ffe38c130161a2697b55a1b779]
@en